Form 4 for CDNA CareDx, Inc.
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-06 · accession 0001217234-21-000253 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-07 | 2021-12-06 | CDNA | Maag Peter | Dir | S - Sale+OE | $41.62 | -10.0K | 341.8K | -3% | -$416.2K |
| DM | 2021-12-07 | 2021-12-06 | CDNA | Maag Peter | Dir | M - OptEx | $18.90 | +10.0K | 351.8K | +3% | +$189.0K |
| DM | 2021-12-07 | 2021-12-06 | CDNA | Maag Peter | Dir | M - OptEx | $0.00 | -10.0K | 7,090 | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-06 | S | D | 6,588 | $41.30 | 345,168 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.56 to $41.54, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Common Stock | 2021-12-06 | S | D | 3,112 | $42.20 | 342,056 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.57 to $42.55, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 3 | Common | Common Stock | 2021-12-06 | S | D | 300 | $42.61 | 341,756 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $42.625, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 4 | Common | Common Stock | 2021-12-06 | M | A | 3,125 | $12.24 | 345,807 | D | — | — | |
| 5 | Common | Common Stock | 2021-12-06 | M | A | 926 | $6.31 | 342,682 | D | — | — | |
| 6 | Common | Common Stock | 2021-12-06 | M | A | 5,949 | $24.35 | 351,756 | D | — | — | |
| 7 | Derivative | Employee Stock Option (right to buy) | 2021-12-06 | M | D | 5,949 | $0.00 | 45,007 | D | $24.35 · — to 2030-02-03 | 5,949 Common Stock | (F8) 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2021-12-06 | M | D | 3,125 | $0.00 | 18,750 | D | $12.24 · — to 2028-06-29 | 3,125 Common Stock | (F7) 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2021-12-06 | M | D | 926 | $0.00 | 7,090 | D | $6.31 · — to 2028-01-19 | 926 Common Stock | (F6) 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |